The launch of a new epinephrine auto-injector is probably still years away, but progress is being made.  Intelliject, Inc. reports that it is in late-state development and has partnered with Sanofi-Aventis US.  They expect to submit a new drug application with the FDA this year, but the product is still a few years to market.

Comments are closed.